The proposed project will explore the role of the informed consent process, knowledge of injection drug use as a risk factor, and other potential predictors of Mexican immigrants? intentions to seek HIV testing. The first phase of the project will entail development of a measure of Mexican immigrants? views of the informed consent process as defined in the United States. The instrument will assess the degree to which recent immigrants find informed consent alienating from communal decision-making and traditional, culturally, defined, individual roles and therefore a deterrent in deciding to voluntarily seek HIV testing. The second phase will entail interviews of 200 recent Mexican immigrants on measures of alienation created by principles of informed consent, knowledge of injection drug use as a risk factor for HIV, concerns about stigma and confidentiality, level of acculturation, and social support. Predictors of intentions to seek HIV testing will be examined with Ordinary Least Squares regression.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Individual Predoctoral NRSA for M.D./Ph.D. Fellowships (ADAMHA) (F30)
Project #
5F30DA014458-05
Application #
6903403
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Hartsock, Peter
Project Start
2002-06-21
Project End
2007-05-20
Budget Start
2005-05-21
Budget End
2006-05-20
Support Year
5
Fiscal Year
2005
Total Cost
$40,044
Indirect Cost
Name
University of Illinois Urbana-Champaign
Department
Miscellaneous
Type
Other Domestic Higher Education
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Horwitz, Russell H; Roberts, Laura Weiss; Warner, Teddy D (2008) Mexican immigrant women's perceptions of health care access for stigmatizing illnesses: a focus group study in Albuquerque, New Mexico. J Health Care Poor Underserved 19:857-73
Joseph, Patrice; Schackman, Bruce R; Horwitz, Russel et al. (2006) The use of an educational video during informed consent in an HIV clinical trial in Haiti. J Acquir Immune Defic Syndr 42:588-91